March 13 (Portaltic/EP) –
Samsung has announced integration into your Samsung Galaxy Tab S8+ tablets from Bottneuro, a solution capable of identifying the areas of the brain affected by Alzheimer’s and storing and recording the data of its therapy.
South Korean technology company has joined with Swiss medical and technology startup Bottneuro AG to offer a simplified graphical interface to help patients get to know the disease in depth and how they respond to it.
Bottneuro AG technology identifies affected brain areas by Alzheimer’s using 3D magnetic resonance imaging and positron emission tomography imaging data. Once identified, these regions can be targeted and electronically stimulated with Miramind’s neurostimulator technology.
Because patients suffering from this disease often experience reduced cognitive function in the early stages of the disease, this collaboration enables Samsung tablets to make Bottneuro AG’s data more accessible.
Samsung has recalled that the Galaxy Tab S8+ Enterprise Edition series is equipped with a high-resolution Super AMOLED screen and that the device also powers the Miamind neurostimulator.
Once the treatment is complete, the information from Bottneuro moves to the company that develops it via a 5G data connection. In addition, this solution is compatible with the security system offered by the South Korean manufacturer, Samsung Knox.
